Children's Hospital, Affiliate of Vilnius University Hospital Santaros klinikos

Vilnius LT-08406

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Urinary Bladder, Neurogenic

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) — Completed
• A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition — Completed